Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE)
Clinical trial NCT03493568 · TERMINATED
Trial details
- NCT number
- NCT03493568
- Sponsor
- IRCCS San Raffaele
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2018-03-20
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.